EP4709370A2 - Stat-abbauer und verwendungen davon - Google Patents

Stat-abbauer und verwendungen davon

Info

Publication number
EP4709370A2
EP4709370A2 EP24804192.3A EP24804192A EP4709370A2 EP 4709370 A2 EP4709370 A2 EP 4709370A2 EP 24804192 A EP24804192 A EP 24804192A EP 4709370 A2 EP4709370 A2 EP 4709370A2
Authority
EP
European Patent Office
Prior art keywords
alkyl
halo
phenyl
compound
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24804192.3A
Other languages
English (en)
French (fr)
Inventor
Howard Bregman
Neil Bifulco
Giovanni Cianchetta
Brian Hodous
Samuel K. REZNIK
Ernest Allen SICKMIER
Yong Tang
Andrew Tasker
Xia TIAN
Rishi G. Vaswani
John Yeoman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recludix Pharma Inc
Original Assignee
Recludix Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recludix Pharma Inc filed Critical Recludix Pharma Inc
Publication of EP4709370A2 publication Critical patent/EP4709370A2/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP24804192.3A 2023-05-09 2024-05-08 Stat-abbauer und verwendungen davon Pending EP4709370A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363465055P 2023-05-09 2023-05-09
PCT/US2024/028326 WO2024233639A2 (en) 2023-05-09 2024-05-08 Stat degraders and uses thereof

Publications (1)

Publication Number Publication Date
EP4709370A2 true EP4709370A2 (de) 2026-03-18

Family

ID=93431152

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24804192.3A Pending EP4709370A2 (de) 2023-05-09 2024-05-08 Stat-abbauer und verwendungen davon

Country Status (2)

Country Link
EP (1) EP4709370A2 (de)
WO (1) WO2024233639A2 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020198435A1 (en) * 2019-03-26 2020-10-01 The Regents Of The University Of Michigan Small molecule degraders of stat3
CA3170503A1 (en) * 2020-03-17 2021-09-23 Nan JI Stat degraders and uses thereof
IL301830A (en) * 2020-10-07 2023-06-01 Kymera Therapeutics Inc Stat degraders and uses thereof
KR20240167786A (ko) * 2022-01-10 2024-11-28 레클루딕스 파마, 인크. Stat 조정제 및 그의 용도

Also Published As

Publication number Publication date
WO2024233639A2 (en) 2024-11-14
WO2024233639A3 (en) 2025-03-27

Similar Documents

Publication Publication Date Title
CA3226206A1 (en) Shp2 inhibitor and use thereof
US20230265116A1 (en) Degradation of (egfr) by conjugation of egfr inhibitors with e3 ligase ligand and methods of use
CA2961607C (en) Mk2 inhibitors and uses thereof
RU2610840C2 (ru) Тиазолопиримидины
US20250215030A1 (en) Stat modulators and uses thereof
JP2022518860A (ja) 免疫調節剤、組成物およびその使用方法
CN115304606B (zh) 一种同时靶向btk和gspt1蛋白的降解剂
US10167281B2 (en) Substituted thiazole or oxazole P2X7 receptor antagonists
US8691804B2 (en) Azetidines and cyclobutanes as histamine H3 receptor antagonists
CA2890983A1 (en) Heteroaryl substituted pyridyl compounds useful as kinase modulators
KR20190034564A (ko) 약학적 화합물
IL283290B1 (en) Cyclic urea
CA3054324C (en) Tri-cycle compound and applications thereof
TW202237597A (zh) 新型egfr降解劑
AU2019344922B2 (en) O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
KR20150092156A (ko) Cb2 수용체 작용제로서 신규한 피라진 유도체
JP2006522824A (ja) 炎症性疾患を処置するために有用なβ−カルボリン
AU2005243188A1 (en) Beta-carbolines useful for treating inflammatory disease
AU2022271927A1 (en) Compound having anti-tumor activity and use thereof
JP7734147B2 (ja) Sstr4アゴニストとしてのn-(ヘテロシクリル及びヘテロシクリルアルキル)-3-ベンジルピリジン-2-アミン誘導体
WO2024238598A2 (en) Stat degraders and uses thereof
JP2023545065A (ja) オートタキシン抑制剤化合物
EP4709370A2 (de) Stat-abbauer und verwendungen davon
EP4262975B1 (de) Heterocyclische derivate als p2x7-rezeptor-antagonisten
WO2024238603A2 (en) Stat degraders and uses thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251102

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR